PHR:NYE-Phreesia Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 25.78

Change

+0.87 (+3.49)%

Market Cap

N/A

Volume

0.59M

Analyst Target

USD 30.11
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-03 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
DOCS Doximity Inc

+2.77 (+5.08%)

USD 11.11B
WEAV Weave Communications Inc

+0.03 (+0.31%)

USD 0.72B
AMWL American Well Corp

N/A

USD 0.11B
CTEV Claritev Corporation

+1.60 (+4.35%)

N/A
HNGE Hinge Health, Inc.

-1.51 (-3.77%)

N/A
EVH Evolent Health Inc

+0.08 (+0.99%)

N/A
TDOC Teladoc Inc

-0.19 (-2.67%)

N/A
VEEV Veeva Systems Inc Class A

+6.37 (+2.25%)

N/A
FOXO FOXO Technologies Inc.

-0.02 (-4.68%)

N/A

ETFs Containing PHR

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.46% 75% C 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.46% 75% C 64% D
Trailing 12 Months  
Capital Gain 38.45% 75% C 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 38.45% 75% C 93% A
Trailing 5 Years  
Capital Gain -11.20% 50% F 29% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -11.20% 50% F 15% F
Average Annual (5 Year Horizon)  
Capital Gain -0.63% 60% D- 33% F
Dividend Return -0.63% 60% D- 21% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 53.05% 70% C- 14% F
Risk Adjusted Return -1.19% 60% D- 24% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector